Home ›› 20 Sep 2020 ›› World Biz
The board of directors of Ibn Sina Pharmaceutical Industry Ltd has recommended a 38.50 per cent cash dividend for the financial year ended on June 30, 2020.
The Dhaka Stock Exchange (DSE) confirmed the information on its website Sunday.
The final approval will come at the annual general meeting (AGM) scheduled to be held at 11:00am on November 12 through a digital platform. The record date is October 12.
The company has reported consolidated earnings per share (EPS) of 12.43 taka, consolidated net asset value (NAV) per share of 56.74 taka and consolidated net operating cash flow per share (NOCFPS) of 14.08 taka for the year ended on June 30, 2020, whereas 10.76 taka (solo), 47.32 taka (solo) and 13.87 taka (solo) respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the company today (Sunday) following its corporate declaration. However, the floor price shall be applicable accordingly as per a Bangladesh Securities and Exchange Commission (BSEC) order issued on March 19, 2020.
